Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Ocgn

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Feb 08, 2021 10:14am

29 Views

Post# 32499749

RE:RE:Ocgn

Watch the American volume today its set to outpace Canadian volume !!!

American's know what we got here ......

bligicka wrote: Lol Canadians are not good at Biotech ..... we will never get that kinda valuation as long as were stuck on the Venture !!!

Jlane17 wrote: Everyone dreaming about Vaxil but ocgn is doing it !!!